Physician profile
Brett P Bielory
NPI 1437592946
$477,148.82
in general payments reported to CMS, 2019-2025
37 companies · $129K in 2025
The $129K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $1,435 · 2021: $14K · 2022: $57K · 2023: $113K · 2024: $162K · 2025: $129K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $196K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $78K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $63K · Travel and Lodging: $48K · Food and Beverage: $14K · Honoraria: $5,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $196,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $77,962.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $62,500.00 |
| Travel and Lodging | $48,070.65 |
| Food and Beverage | $14,496.61 |
| Honoraria | $5,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $249,112.59 | 2019-2025 | |
| Rayner Intraocular Lenses Limited | $90,968.65 | 2023-2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Bausch & Lomb Americas INC. | $52,000.86 | 2022-2025 | Envista Mx60 Iol, Envista Envy Iol, Envista Aspire Iol |
| Topcon Healthcare, INC. | $40,212.37 | 2019-2025 | |
| Carl Zeiss Meditec, INC. | $10,277.00 | 2023-2025 | Iolmaster 700, Visumax, Cirrus Hd-Oct |
| Amgen INC. | $8,564.13 | 2024-2025 | Tepezza |
| Ocular Therapeutix, INC. | $7,903.80 | 2020-2025 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $7,409.97 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $4,365.79 | 2021-2025 | Oxervate |
| Alcon Vision LLC | $926.72 | 2019-2025 | Rocklatan, Hydrus Microstent, Clareon |
| Horizon Therapeutics Plc | $657.25 | 2023 | Tepezza |
| Sight Sciences, INC. | $626.94 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Novartis Pharmaceuticals Corporation | $460.66 | 2019-2022 | |
| Glaukos Corporation | $451.43 | 2021-2025 | Idose, Photrexa Viscous and Photrexa, Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $379.43 | 2020-2025 | Tecnis Simplicity, Tecnis Iol, Catalys System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $317.37 | 2022-2025 | |
| Harrow Eye, LLC | $291.78 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $290.77 | 2021-2025 | Cequa |
| Allergan, INC. | $197.53 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $178.77 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $178.17 | 2024-2025 | Acthar |
| Integra Lifesciences Corporation | $153.14 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lumenis, INC | $148.96 | 2019 | |
| Astellas Pharma US INC | $140.00 | 2025 | Izervay |
| Eyevance Pharmaceuticals LLC | $135.45 | 2020-2022 | |
| Beaver-Visitec International, INC. | $119.66 | 2020-2025 | |
| Carl Zeiss Meditec USA, INC. | $110.47 | 2022-2023 | Quatera 700 |
| New World Medical,INC. | $106.79 | 2020 | |
| Haag-Streit USA, INC. | $89.79 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $81.88 | 2020-2021 | |
| Ivantis, INC | $63.93 | 2021 | |
| Maculogix, INC. | $55.24 | 2020 | |
| Oyster Point Pharma, INC. | $46.88 | 2022-2024 | Tyrvaya |
| Lensar, INC. | $42.22 | 2025 | Lensar Laser System |
| Ortho-Clinical Diagnostics, INC. | $38.86 | 2024 | Inflammadry |
| Rxsight INC | $24.21 | 2021 | |
| Bioventus LLC | $19.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Bielory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.